Stay updated with breaking news from Isk Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced positive...
/PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, has announced today...
Industry news related to corporate real estate, economic development trends, site selection information and corporate expansion throughout the Asia-Pacific region.
/PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe,...
SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch, SK Bioscience USA.